- $1.70bn
- $1.49bn
- $69.65m
Personalis rises on expanded Medicare coverage for cancer test
Brief: Personalis Receives Medicare Coverage For Next Personal For Immunotherapy Monitoring Across Late-Stage Solid Tumors
Personalis Q1 revenue falls but beats analyst estimates
Personalis Q4 revenue slightly misses expectations
U.S. STOCKS ON THE MOVE-Target, Warner Bros Discovery , Copper miners
U.S. STOCKS ON THE MOVE-Zimmer Biomet, Datadog, Ecolab
U.S. STOCKS ON THE MOVE-Vistra Corp, Quest Diagnostics, Jacobs Solutions
U.S. STOCKS ON THE MOVE-Spotify, DuPont, Hasbro
Personalis rises as Medicare extends coverage to lung cancer test
Brief: Personalis Inc Receives Medicare Coverage For Next Personal In Lung Cancer Surveillance
Brief: Personalis Reports Select Preliminary Fourth Quarter And Full Year 2025 Results
Brief: Personalis Announces New Publication Applying Ultrasensitive CtDNA Testing
Brief: Personalis Says CMS Revises Reimbursement Rate For Personal Test For Post-Treatment Surveillance Of Cancers
Healthcare firm Personalis beats Q3 revenue estimates
Brief: Personalis Q3 Net Income USD -21.652 Million
U.S. STOCKS ON THE MOVE-Bitfarms, Progyny, ManpowerGroup
U.S. STOCKS ON THE MOVE-DoorDash, Praxis, Snowflake
Personalis rises as blood test detects lung cancer months before imaging
Brief: Personalis Announces New Data From A Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing